+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals



Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals



European Journal Of Biochemistry. 221(1): 285-295



The dithiol trypanothione, novel to trypanosomatids and analogous to glutathione in mammalian systems, has been shown to interact with anti-trypanocidal trivalent arsenical drugs forming a stable adduct, MelT. This adduct is a competitive inhibitor of the flavoprotein trypanothione reductase, responsible for maintaining intracellular trypanothione in the reduced form. Since trypanothione reductase and the analogous glutathione reductase both contain catalytically active sulphydryl groups we have examined the ability of several arsenicals to differentially inhibit these enzymes. Melarsen oxide (p-(4,6-diamino-s-triazin-2-yl)aminophenylarsenoxide) potently inhibits both enzymes in two stages, the first being essentially complete within 1 min, the second being time dependent, exhibiting saturable pseudo-first-order kinetics with k-inact of 14.3 times 10-4 s-1 and 1.06 times 10-4 s-1 and K-i of 17.2 mu-M and 9.6 mu-M for trypanothione reductase and glutathione reductase, respectively. Inhibition requires prior reduction of the enzyme by NADPH and can be reversed by excess dithiols or prevented by MelT in the case of trypanothione reductase. In both cases a time-dependent loss of the characteristic charge-transfer absorbance band at 530 nm is observed upon addition of arsenical to pre-reduced enzyme, which with excess NADPH leads to a spectrum resembling the EH-4 form and is accompanied by an increased ability to reduce molecular oxygen. A model for inhibition is proposed where, first, free arsenical and previously reduced enzyme immediately establish an equilibrium with an inactive monothioarsane enzyme-inhibitor complex involving the interchange cysteine distal to the FAD; second, a subsequent rearrangement about the sulphur-arsenic bond leads to the binding of the arsenical to the charge-transfer cysteine, proximal to the FAD, forming a more stable dithioarsane complex. Molecular modelling suggests that the differences in kinetic behaviour of the two enzymes can be attributed to structural features of their respective disulphide-binding sites. Incubation of reduced trypanothione reductase with excess dihydrotrypanothione and melarsen oxide prevents direct inhibition of the enzyme, suggesting that dihydrotrypanothione acts as a protectant in vivo, preventing the direct modification of trypanothione reductase by sequestering the arsenical as MelT.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 009002664

Download citation: RISBibTeXText

PMID: 8168518

DOI: 10.1111/j.1432-1033.1994.tb18740.x


Related references

Naegleria fowleri: a free-living highly pathogenic amoeba contains trypanothione/trypanothione reductase and glutathione/glutathione reductase systems. Experimental Parasitology 114(3): 141-146, 2006

Trypanothione reductase from Leishmania donovani. Purification, characterisation and inhibition by trivalent antimonials. European Journal of Biochemistry 230(2): 460-468, 1995

Differential susceptibility of filarial and human erythrocyte glutathione reductase to inhibition by the trivalent organic arsenical melarsen oxide. Molecular & Biochemical Parasitology 71(2): 211-219, 1995

Interference by glutathione reductase in the creatine kinase mb inhibition test elimination of the catalytic activity of glutathione reductase by anti glutathione reductase. Journal of Clinical Chemistry and Clinical Biochemistry 16(4): 253-254, 1978

Interference by glutathione reductase in the "CK-MB-inhibition-test": elimination of the catalytic activity of glutathione reductase by anti-glutathione reductase. Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift für Klinische Chemie und Klinische Biochemie 16(4): 253-254, 1978

The inhibiting effects of N- and N- substituted polyamine derivatives on trypanothione reductase and glutathione reductase. Abstracts of Papers American Chemical Society 223(1-2): CHED 686, 2002

Redox enzyme engineering conversion of human glutathione reductase into a trypanothione reductase. Biochemistry 30(25): 6124-6127, 1991

The antioxidant enzymes glutathione reductase and trypanothione reductase as drug targets. Unknown, 1991

Raman studies of flavins and the flavoenzymes trypanothione reductase and glutathione reductase. Biophysical Journal 70(2 PART 2): A295, 1996

Photoinactivation of trypanothione reductase and glutathione reductase by Al-phthalocyanine tetrasulfonate and hematoporphyrin. Biochemical and Biophysical Research Communications 218(2): 629-632, 1996

Evidence for the co-existence of glutathione reductase and trypanothione reductase in the non-trypanosomatid Euglenozoa: Euglena gracilis Z. FEBS Letters 442(1): 29-33, 1999

Charge is the major discriminating factor for glutathione reductase versus trypanothione reductase inhibitors. Bioorganic & Medicinal Chemistry 4(8): 1247-1253, 1996

Docking and molecular dynamics studies at trypanothione reductase and glutathione reductase active sites. Journal of Molecular Modeling 8(5): 173-183, 2002

Synthesis of symmetric disulfides as potential alternative substrates for trypanothione reductase and glutathione reductase: Part 1. Amino Acids 9(4): 327-342, 1995